| Financial Year |
March 31 2023 |
| Monetary Funds |
32,457,369.46 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
136,088,675.39 |
| Advances to Suppliers |
32,366,446.62 |
| Other Receivables |
72,016,721.70 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
134,320,356.28 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
14,870,828.98 |
| Total Current Assets |
425,468,591.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
346,238,078.50 |
| Fixed Assetes |
1,091,629,807.42 |
| Under-construction Projects |
15,624,953.85 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
123,662,841.63 |
| R&D expenses |
-- |
| Goodwill |
1,321,572.04 |
| Long-Term Deferred and Prepaid Expenses |
29,621,362.14 |
| Deferred Income Tax Assets |
15,924,952.94 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,652,585,574.79 |
| Total Assets |
2,078,054,165.79 |
| Short-Term Loans |
163,642,433.17 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
66,292,608.09 |
| Accounts Received In Advance |
61,570,028.09 |
| Employee Compensation Payable |
49,575,008.29 |
| Taxes Payable |
40,605,953.94 |
| Interest Payable |
-- |
| Dividend Payable |
3,597,984.21 |
| Other payables |
337,434,901.73 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
926,497,916.38 |
| Other Current Liabilities |
2,461,524.83 |
| Sub-Total of Current Liabilities |
1,667,733,665.19 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
11,123,505.11 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
61,932,476.66 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
114,215,793.66 |
| Total Liabilities |
1,781,949,458.85 |
| Paid-In Capital(Or Share Stock) |
1,285,702,520.00 |
| Capital Surplus |
281,232,445.03 |
| Surplus Reserve |
365,822,127.76 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,666,029,800.35 |
| Minority Stockholder's Interest |
-83,041,887.28 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
379,146,594.22 |
| Owner's Equity（Stockholder's Equity） |
296,104,706.94 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,078,054,165.79 |
